[引用][C] Assessing Changes in Circulating Tumor Cells (CTCs) during Preoperative Chemoradiotherapy for Gastrointestinal Malignancies Using a Nanotechnology …
SN Seyedin, CM Callaghan, M Poellmann… - International Journal of …, 2019 - redjournal.org
Results A total of 12 patients have enrolled. Baseline, mid-, and end treatment CTCs are
available for 11, 8, and 7 patients, respectively. Median patient age is 60.5 (range 44-81).
One patient had esophageal adenocarcinoma, 5 had pancreatic adenocarcinoma, and 6
had rectal adenocarcinoma. Eight patients had node positive disease and 8 received
induction chemotherapy before chemoradiation. CTCs were detected in all patients at
baseline with a median 15.5 CTCs/ml (Table 1). Median CTCs significantly decreased at mid …
available for 11, 8, and 7 patients, respectively. Median patient age is 60.5 (range 44-81).
One patient had esophageal adenocarcinoma, 5 had pancreatic adenocarcinoma, and 6
had rectal adenocarcinoma. Eight patients had node positive disease and 8 received
induction chemotherapy before chemoradiation. CTCs were detected in all patients at
baseline with a median 15.5 CTCs/ml (Table 1). Median CTCs significantly decreased at mid …
以上显示的是最相近的搜索结果。 查看全部搜索结果